Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Antineoplastic cephalomannine derivatives from Xechem with paclitaxel-like activity

Dec. 21, 1998

Techniclone's Rx for B-cell NHL qualifies for orphan designation

Dec. 18, 1998

NIH offers new patented therapy for primary brain tumors for licensing

Dec. 18, 1998

Novel orally active tumor angiogenesis inhibitors licensed by Cell Therapeutics

Dec. 18, 1998

Pivotal clinical trials begin for Epic's sustained-release LHRH analogue

Dec. 18, 1998

British Biotech discontinues marimastat monotherapy study in ovarian cancer

Dec. 17, 1998

Liposome Co. files for approval of Evacet in U.S.

Dec. 17, 1998

Orphan Medical files NDS for Busulfex Injection in Canada

Dec. 17, 1998

Merck KGaA prefers alliances to mergers; signs new deal with ImClone Systems

Dec. 16, 1998

Phase II trials of Xenova's P-gp pump inhibitor planned in U.S. and U.K.

Dec. 16, 1998

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...